Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

John Fowler Biography and Net Worth

EVP of Oracle

John Fowler is Executive Vice President of Systems. Mr. Fowler has extensive experience in corporate strategy as well as systems and software development. Before coming to Oracle in 2010, when the company acquired Sun, he worked at Sun for more than 14 years, where he served in several influential roles, including Executive Vice President of Sun’s Systems Group; Chief Technology Officer for Sun’s Software organization; and Executive Vice President of Sun’s x64 Systems Group, focused on delivering industry-standard network computing systems for Solaris, Linux, and Windows. At Oracle, Mr. Fowler continues to be responsible for the delivery of all Sun systems products, including SPARC and x64-based servers, as well as networking and disk and tape storage products. Additionally, he is responsible for systems software, including Oracle Solaris.

What is John F. Fowler's net worth?: The estimated net worth of John F. Fowler is at least $30.98 million as of March 30th, 2017. Mr. Fowler owns 269,645 shares of Oracle stock worth more than $30,976,818 as of April 19th. This net worth approximation does not reflect any other investments that Mr. Fowler may own. Learn More about John F. Fowler's net worth.
How do I contact John F. Fowler?: The corporate mailing address for Mr. Fowler and other Oracle executives is 500 ORACLE PARKWAY, REDWOOD CITY CA, 94065. Oracle can also be reached via phone at (737) 867-1000 and via email at [email protected]. Learn More on John F. Fowler's contact information.
Has John F. Fowler been buying or selling shares of Oracle?: John F. Fowler has not been actively trading shares of Oracle during the past quarter. Most recently, John F. Fowler sold 250,000 shares of the business's stock in a transaction on Thursday, March 30th. The shares were sold at an average price of $44.66, for a transaction totalling $11,165,000.00. Following the completion of the sale, the executive vice president now directly owns 269,645 shares of the company's stock, valued at $12,042,345.70. Learn More on John F. Fowler's trading history.
Who are Oracle's active insiders?: Oracle's insider roster includes Jeffrey Berg (Director), Michael Boskin (Director), Safra Catz (CEO), George Conrades (Director), Dorian Daley (EVP), Lawrence Ellison (Chairman), Rona Fairhead (Director), John Fowler (EVP), Jeffrey Henley (Vice Chairman), Renee James (Director), Charles Moorman (Director), Edward Screven (Insider), Naomi Seligman (Director), Maria Smith (EVP), and W. West (CAO). Learn More on Oracle's active insiders.
Are insiders buying or selling shares of Oracle?: In the last year, insiders at the enterprise software provider sold shares 12 times. They sold a total of 4,986,393 shares worth more than $612,878,144.54. The most recent insider tranaction occured on March, 26th when CEO Safra Catz sold 790,000 shares worth more than $99,966,600.00. Insiders at Oracle own 42.8% of the company. Learn More about insider trades at Oracle.
Information on this page was last updated on 3/26/2024.

John F. Fowler Insider Trading History at Oracle

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/30/2017	Sell	250,000	$44.66	$11,165,000.00	269,645
8/11/2016	Sell	500,000	$41.17	$20,585,000.00	119,645
3/31/2016	Sell	14,971	$40.92	$612,613.32	5,016
7/25/2014	Sell	590,000	$40.46	$23,871,400.00

John F. Fowler Buying and Selling Activity at Oracle

Oracle Company Overview

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing. The company also offers cloud-based industry solutions for various industries; Oracle application licenses; and Oracle license support services. In addition, it provides cloud and license business' infrastructure technologies, such as the Oracle Database and MySQL Database; Java, a software development language; and middleware, including development tools and others. The company's cloud and license business' infrastructure technologies also comprise cloud-based compute, storage, and networking capabilities; and Oracle autonomous database, MySQL HeatWave, Internet-of-Things, digital assistant, and blockchain. Further, it provides hardware products and other hardware-related software offerings, including Oracle engineered systems, enterprise servers, storage solutions, industry-specific hardware, virtualization software, operating systems, management software, and related hardware services; and consulting and customer services. The company markets and sells its cloud, license, hardware, support, and services offerings directly to businesses in various industries, government agencies, and educational institutions, as well as through indirect channels. The company has a collaboration with Amdocs Limited to empower customers on their journey towards cloud and digital adoption. Oracle Corporation was founded in 1977 and is headquartered in Austin, Texas.

Today's Range

Now: $114.88

$114.46

$116.77

50 Day Range

MA: $119.27

$108.16

$129.24

2 Week Range

Now: $114.88

$93.29

$132.77

Volume

8,168,854 shs

Average Volume

8,593,096 shs

Market Capitalization

$315.75 billion

P/E Ratio

30.31

Dividend Yield

1.35%

Beta

1.01

Tiny Biotech Stock Wins $75 Billion Patent

From Behind the Markets | Ad

Find out more here >>>